Marlborough, MA-based Hologic HOLX is navigating a shifting geopolitical landscape in each of its core businesses. In a conservative move, the company’s fiscal 2025 sales outlook now excludes the HIV ...
MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds ...
On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions ...
Hologic HOLX offers a wide range of diagnostic products to help in the screening and diagnosis of human disease. Although the performance of the Diagnostics segment in recent quarters has been ...
With a market cap of $18.9 billion, Marlborough, Massachusetts-based Hologic, Inc. (HOLX) focuses on diagnostics, imaging systems, and surgical products for women’s health. Through its four segments: ...
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced the completion of its acquisition by funds managed by Blackstone and TPG in a transaction valued at up to $79 per share ...
Hosted on MSN
Hologic (NASDAQ:HOLX) Exceeds Q3 Expectations
Medical technology company Hologic (NASDAQ:HOLX) announced in Q3 CY2025, with sales up 6.2% year on year to $1.05 billion. Its non-GAAP profit of $1.13 per share was 2.7% above analysts’ consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results